Author:
Molnár Z.,Nierhaus A.,Esen F.
Publisher
Springer Berlin Heidelberg
Reference30 articles.
1. Martin G, Brunkhorst FM, Janes JM et al (2009) The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes. Crit Care 13:R103
2. Ranieri VM, Thompson BT, Barie PS et al (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064
3. Werdan K (2001) Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins. Ther Apher 5:115–122
4. Taccone FS, Stordeur P, De Backer D, Creteur J, Vincent JL (2009) γ-globulin levels in patients with community-acquired septic shock. Shock 32:379–385
5. Alejandria MM, Lansang MA, Dans LF, Mantaring JB (2002) Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev CD0011090
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献